Chronic Lymphocytic Leukemia Clinical Trials in Fort Wayne, Indiana

4 studies are recruiting for chronic lymphocytic leukemia in Fort Wayne, Indiana right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

    The goal of this study is to evaluate nemtabrutinib compared with investigator's choice of ibrutinib or acalabrutinib in participants with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) who have not received any prior therapy. The primary hypotheses are that (1) nemtabrutinib i…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Parkview Research Center at Parkview Regional Medical Center ( Site 0002), Fort Wayne, Indiana
    Locations
    203 in total
    Run by
    Merck Sharp & Dohme LLC

    See if you can join NCT06136559 on ClinicalTrials.gov

  2. Study of NX-5948 Versus Pirtobrutinib in R/R CLL/SLL

    The study will evaluate the efficacy and safety of NX-5948 (bexobrutideg) versus pirtobrutinib in participants with relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) who are relapsed or refractory to prior covalent Bruton tyrosine kinase inhibitor (cBTKi)…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Fort Wayne Medical Oncology and Hematology, Fort Wayne, Indiana
    Locations
    6 in total
    Run by
    Nurix Therapeutics, Inc.

    See if you can join NCT07516093 on ClinicalTrials.gov

  3. A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.

    The purpose of this study is to establish the safety of novel dosing and ramp-up schedules for sonrotoclax in participants with hematological malignancies.

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Fort Wayne Medical Oncology and Hematology, Fort Wayne, Indiana
    Locations
    17 in total
    Run by
    BeOne Medicines

    See if you can join NCT06697184 on ClinicalTrials.gov

  4. AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma

    This is an open-label, multi-center Phase 1b clinical study of oral AS-1763 (docirbrutinib) in patients with CLL/SLL or B-cell NHL who have failed or are intolerant to ≥2 lines of systemic therapy.

    Stage
    Phase 1
    Ages
    18 and older
    Site
    American Oncology Partners, Fort Wayne, Indiana
    Locations
    13 in total
    Run by
    Carna Biosciences, Inc.

    See if you can join NCT05602363 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.